Page 15 - சர்வதேச இதழ் ஆஃப் தொற்று நோய்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Activists Fueling Concerns About Vaccine Safety
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
365 days since 1st Covid death in India: Experts reveal strategy behind low fatality rate
365 days since 1st Covid death in India: Experts reveal strategy behind low fatality rate
March 12 marks one year since India reported its first coronavirus-related death. Healthcare experts and epidemiologists weighed in on how India managed to keep its fatality rate in check.
advertisement
[REPRESENTATIVE IMAGE] File photo of a mural in Delhi depicting Corona Warriors (Photo Credits: PTI)
HIGHLIGHTS
South Asian countries have a younger population compared with other countries
No evidence of lesser virulent strains in India: Professor Gagandeep Kang
On March 12, 2020, a 76-year-old person, a returnee from Saudi Arabia became the first recorded victim of Covid-19 in India. A whole year has passed since and the country has recorded 11,308,846 cases of infection and 1,58,326 Covid-related deaths to date.
6 Min Read
(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS.
Some common-cold antibodies might help fight COVID-19
Antibodies to the six coronaviruses that cause common colds cannot neutralize the coronavirus that causes COVID-19, but antibodies to two of them might at least help the body fend off severe illness from the new virus, a small preliminary study suggests. German researchers studied 60 patients with COVID-19, including 25 who were hospitalized but not critically ill, 19 who required intensive care unit admission, and 25 who did not get
vimarsana © 2020. All Rights Reserved.